Veeva Systems
Veeva Systems is a company.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at Veeva Systems.
Veeva Systems is a company.
Key people at Veeva Systems.
Key people at Veeva Systems.
Veeva Systems Inc. (VEEV) is a leading cloud-based software provider exclusively serving the global life sciences industry, including pharmaceuticals, biotechnology, and medical devices.[1][2][3] It builds an integrated suite of solutions like Veeva CRM for customer relationship management, Veeva Vault for content and data management, and Veeva Network for master data, helping companies streamline operations from R&D to commercialization while ensuring regulatory compliance and accelerating product market entry.[1][3][5][6] Veeva solves complex challenges in highly regulated sectors—such as inefficient paper-based processes, disparate data, and collaboration hurdles—by delivering scalable, cloud-native tools that boost efficiency, innovation, and patient outcomes for over 1,000 customers worldwide, from emerging biotechs to industry giants.[3][4][5] Its mission is to empower life sciences with innovative software that drives efficiency and compliance, positioning it as an indispensable partner amid digital transformation.[1][2][4]
The company exhibits strong growth momentum, with flagship products like Veeva CRM gaining significant traction and ongoing expansions into AI capabilities on the Veeva Vault platform, including initial releases by late 2025.[2][5]
Veeva Systems was founded in 2007 by Peter Gassner and Matt Wallach, who recognized the need for specialized cloud software in the rigid, regulated life sciences sector.[4][8] Gassner, with prior experience at Salesforce, and Wallach leveraged their expertise in CRM and enterprise software to launch Veeva CRM as the flagship product, revolutionizing customer relationship management for pharmaceuticals by replacing outdated, non-scalable systems.[5] Early traction came from addressing pain points like manual processes and compliance risks, quickly gaining adoption among life sciences firms and enabling Veeva to expand its portfolio to comprehensive cloud solutions.[1][3][5] Pivotal moments include establishing a global presence across North America, Europe, Asia, and Latin America, and evolving into a public benefit corporation (PBC) committed to industry productivity and quality employment.[2][3][6][7]
Veeva rides the wave of digital transformation in life sciences, where cloud adoption, AI, and data unification are displacing paper-based, fragmented systems amid rising regulatory pressures and demands for faster drug development.[2][3][4] Timing is ideal: post-pandemic acceleration in biotech innovation and global market expansion favors Veeva's established leadership, serving a massive addressable market of complex, high-stakes operations.[1][2][5] Favorable forces include regulatory evolution requiring compliance tech, scalability for emerging biotechs, and AI integration for efficiency gains.[2][4] Veeva influences the ecosystem by setting standards for industry cloud solutions, enabling over 1,000 firms to prioritize life-saving R&D, and driving broader adoption of compliant, collaborative tech that advances science and patient lives.[3][4][6]
Veeva is poised for sustained dominance through AI enhancements on its Vault platform (rolling out by December 2025) and geographic/market expansions, further solidifying its role as the go-to backbone for life sciences digital ops.[2][4] Key trends like AI-powered clinical management, personalized medicine, and stricter global regs will propel demand, while its PBC model ensures resilient, customer-aligned growth.[6][7] Influence may evolve toward ecosystem orchestration, partnering deeper with biotechs and CROs to shape next-gen therapies—reinforcing its mission to make life sciences more productive from day one.[1][3]
